Skip to main content
. 2024 Mar 12;14:5968. doi: 10.1038/s41598-024-55374-1

Table 1.

Descriptive analysis of hand OA on PROCOAC cohort.

Mean (SD) Median n (%)
Age at diagnosis 62.95 (9.09) 63.00
Sex
 Male 181 (17.42)
 Female 858 (82.58)
BMI 29.68 (17.27) 28.60
Abdominal perimeter 95.22 (12.32) 95.00
Hypertension 499 (48.21)
Diabetes 186 (18.02)
Dyslipidemia 660 (58.67)
Hypertriglyceridemia 168 (16.80)
Low HDL 95 (9.46)
MetS 202 (19.55)
Osteoporosis 166 (15.98)
Osteopenia 107 (10.30)
Smoking habit
 Never 659 (63.73)
 Current 253 (24.47)
 Former 122 (11.80)
Psoriasis 87 (8.41)
Total AUSCAN 45.49 (29.35) 48.80
Pain AUSCAN 47.32 (31.15) 50.40
Stiffness AUSCAN 44.05 (35.71) 50.00
Function AUSCAN 44.64 (30.34) 48.78
Knee OA (KL > I) 713 (70.52)
Hip OA 515 (51.55)
EHOA 303 (29.16)
Inflammatory hand OA 117 (11.35)
Nodular hand OA 856 (83.84)
Thumb base OA 649 (63.26)
ESR 19.71 (14.47) 16.00
CRP 0.39 (0.88) 0.21
Positive RF 81 (8.67)
Positive ACPA 12 (1.39)

BMI, body mass index (Kg/m2); HDL, high-density lipoprotein; MetS, metabolic syndrome; Knee OA, OA at least in one knee; Hip OA, OA at least in one hip; EHOA, erosive hand osteoarthritis at least in one hand; Inflammatory hand OA, OA at least in one hand; Nodular hand OA, OA at least in one hand; Thumb base OA, OA at least in one hand; ESR, erythrocyte sedimentation rate (mmHg); CRP, C-reactive protein (mg/dL); RF, rheumatoid factor; ACPA, anti-citrullinated protein antibodies.